½ÃÀ庸°í¼­
»óǰÄÚµå
1708409

ºñħ½ÀÀû Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ±â¼úº°, ¸ð´Þ¸®Æ¼º°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°

Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, By Modality, By End User, By Geography .

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ºñħ½ÀÀû Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2025³â¿¡ 2,430¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2032³â±îÁö 6,830¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁöÀÇ CAGRÀº 15.9%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â ½ÃÀå ±Ô¸ð(2025³â) 2,430¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR : 15.90% °¡Ä¡ ¿¹Ãø(2032³â) 6,830¸¸ ´Þ·¯
±×¸². ºñħ½ÀÀû Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå Á¡À¯À²(%), Áö¿ªº°(2025³â)
Non-Invasive Blood Glucose Monitoring Devices Market-IMG1

ºñħ½ÀÀû Ç÷´ç ¸ð´ÏÅ͸µÀº Àΰ£ÀÇ Á¶Á÷¿¡ ¼Õ»óÀ» ÁÖÁö ¾ÊÀ¸¸é¼­ Ç÷´çÀ» °ËÃâÇÏ´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. ±×¸®°í °æÁ¦ÀûÀÌ°í °íÅë¾ø´Â Ç÷´ç ¸ð´ÏÅ͸µ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ±â±â´Â äÇ÷ ´ë½Å ÇǺΠ±ÙóÀÇ Ç÷°üÀ» ½ºÄµÇÏ¿© ÀÛµ¿ÇÕ´Ï´Ù. ±¤´ë¿ª ·¹ÀÌ´õ µîÀÇ Æ÷µµ´ç °ËÃâ ±â¼úÀÇ °³¹ß¿¡ ÀÇÇØ ħ½ÀÀûÀÎ ¸ð´ÏÅ͸µ ¹æ¹ý¿¡ ÀÇÇÑ ÃøÁ¤Ä¡¸¦ Ãæ½ÇÇÏ°Ô ¹Ý¿µÇÒ ¼ö ÀÖ´Â ºñħ½ÀÀûÀÎ Á¦Ç°ÀÇ °³¹ßÀÌ ¿ëÀÌÇØÁ³½À´Ï´Ù.

½ÃÀå ¿ªÇÐ :

ºñħ½ÀÀû Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ¼¼°èÀÇ ´ç´¢º´ À¯º´·ü Áõ°¡¿Í Áö¼ÓÀûÀÎ Æ÷µµ´ç ¸ð´ÏÅ͸µ ±â¼úÀÇ Áøº¸¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. °íÁ¤¹Ðµµ¸¦ ´Þ¼ºÇϱâ À§ÇÑ ±â¼úÀû ÇѰè, ºÒÃæºÐÇÑ ÀÓ»óÀû °ËÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ Áö¿¬ µîÀÇ ¿äÀÎÀÌ ¿©ÀüÈ÷ º¸±ÞÀ» ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù.

Áö½Ä°ú Áø´ÜÀÇ ºÎÁ·Àº ¿¹Ãø ±â°£ µ¿¾È ¼¼°èÀÇ ºñħ½ÀÀû Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ ºñħ½ÀÀû Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð ¹× º¹ÇÕ¿¬°£ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.
  • ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ¼ºÀå ±âȸ¸¦ ÇØ¸íÇϰí, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇϰí ÀÖ½À´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¼ºÀå ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ Ãâ½Ã³ª ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.
  • ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ÆÄ¶ó¹ÌÅÍ¿¡ ±Ù°ÅÇØ, ¼¼°èÀÇ ºñħ½ÀÀû Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ Á¶»ç º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä ±â¾÷Àº Baxter International Inc., Dexcom, Inc., Abbott, Medtronic, Senseonics Holdings, Inc., GlySens Incorporated, DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc. Inc., NovioSense BV, Quick LLC, RSP Systems A/S µîÀÌ ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­·ÎºÎÅÍÀÇ ÀλçÀÌÆ®¿¡ ÀÇÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ³ª ±â¾÷ÀÇ °æ¿µÁøÀº Àå·¡ÀÇ Á¦Ç° ¹ß¸Å, À¯Çü ¾÷, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ °üÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ ÀÇ»ç °áÁ¤À» ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ÀÌ Á¶»ç º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, ÆÇ¸ÅÀÚ, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µîÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°èÀÇ ºñħ½ÀÀû Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç °áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • ÀϰüµÈ ±âȸ ¸Ê(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
  • ÁßÁõ±Ù¹«·ÂÁõÀ̳ª ¼ö¼ú ÈÄ ÀåÆó»ö µî, ³×¿À½ºÆ¼±×¹ÎÀ» ÇÊ¿ä·Î ÇÏ´Â ÁúȯÀÇ ÀÌȯÀ² »ó½Â
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • Áö½Ä°ú Áø´ÜÀÇ ºÎÁ·
    • ±âȸ
  • ¼öÀÇÇÐÀÇ ¼ºÀå
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° Ãâ½Ã/½ÂÀÎ
  • PEST ºÐ¼®
  • PORTER ºÐ¼®
  • ÇÕº´°ú Àμö ½Ã³ª¸®¿À

Á¦4Àå ¼¼°èÀÇ ºñħ½ÀÀû Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) À¯ÇàÀÇ ¿µÇâ

  • COVID-19 ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃøÀÇ ºÐ¼®
  • °æÁ¦¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ºñħ½ÀÀû Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå, ±â¼úº°(2020-2032³â)

  • EM ÆÄµ¿
  • °æÇÇ
  • ±¤ÇÐ
  • È¿¼Ò

Á¦6Àå ¼¼°èÀÇ ºñħ½ÀÀû Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå, ¸ð´Þ¸®Æ¼º°(2020-2032³â)

  • ¿þ¾î·¯ºí
  • ºñ¿þ¾î·¯ºí/º¥Ä¡Å¾
  • ÀÓº£µðµå ±â±â

Á¦7Àå ¼¼°èÀÇ ºñħ½ÀÀû Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°(2020-2032³â)

  • º´¿ø
  • Ŭ¸®´Ð
  • ÀçÅà Äɾî ȯ°æ

Á¦8Àå ¼¼°èÀÇ ºñħ½ÀÀû Ç÷´ç ¸ð´ÏÅ͸µ ±â±â ½ÃÀå, Áö¿ªº°(2020-2032³â)

  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • Baxter International Inc.
  • Dexcom, Inc
  • Abbott
  • Medtronic
  • Senseonics Holdings, Inc
  • GlySens Incorporated
  • DiaMonTech GmbH
  • Nemaura Medical Inc.
  • Integrity Applications, Inc.
  • CNOGA Medical Ltd
  • Breath Health, Inc.
  • Metamaterial Technologies Inc.
  • Opticology Inc.
  • NovioSense BV
  • Quick LLC
  • RSP Systems A/S.

Á¦10Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
KTH 25.05.19

Global Non-Invasive Blood Glucose Monitoring Devices Market is estimated to be valued at USD 24.3 Mn in 2025 and is expected to reach USD 68.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 15.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 24.3 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 15.90% 2032 Value Projection: USD 68.3 Mn
Figure. Non-Invasive Blood Glucose Monitoring Devices Market Share (%), By Region 2025
Non-Invasive Blood Glucose Monitoring Devices Market - IMG1

Non-invasive blood glucose monitoring, as its name implies, refers to the detection of human blood glucose without causing damage to human tissues. Non-invasive blood glucose monitoring devices offer an economical and pain-free method to monitor blood glucose levels compared to traditional finger-pricking methods. These devices work by scanning the blood vessels near the skin instead of drawing blood. Advancement in glucose sensing technologies, such as minimally-invasive micro needles, near infrared spectroscopy, and ultra wideband radar, have facilitated the development of non-invasive products that can closely mirror readings from invasive monitoring methods. This provides diabetics with greater convenience and compliance in managing their condition. Non-invasive blood glucose monitoring devices can be segmented on the basis of technology into EM waves, transdermal, optical, and enzymatic.

Market Dynamics:

The non-invasive blood glucose monitoring devices market is driven by the growing prevalence of diabetes worldwide as well as advancements in continuous glucose monitoring technologies. Many new players are entering the market with novel solutions that can help overcome the challenges with existing invasive methods like finger pricks. However, factors such as technical limitations in achieving high accuracy compared to reference methods, insufficient clinical validation, and slow regulatory approvals continue to restrain widespread adoption. Nonetheless, continued R&D focusing on improved algorithms and sensors offers promising opportunities for non-invasive solutions to become a viable alternative to conventional glucose tests.

Lack of knowledge and diagnosis are expected to hamper the growth of the global non-invasive blood glucose monitoring devices market over the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global non-invasive blood glucose monitoring devices market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global non-invasive blood glucose monitoring devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Baxter International Inc., Dexcom, Inc, Abbott, Medtronic, Senseonics Holdings, Inc, GlySens Incorporated, DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global non-invasive blood glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global non-invasive blood glucose monitoring devices market

Detailed Segmentation:

  • Global non-invasive blood glucose monitoring devices Market, By Technology:
    • EM Waves
    • Transdermal
    • Optical
    • Enzymatic
  • Global non-invasive blood glucose monitoring devices Market, By Modality:
    • Wearable
    • Non-wearable/Benchtop
    • Embedded Devices
  • Global non-invasive blood glucose monitoring devices Market, By End User:
    • Hospitals
    • Clinics
    • Homecare setting
  • Global non-invasive blood glucose monitoring devices Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profile:
    • Baxter International Inc.
    • Dexcom, Inc
    • Abbott
    • Medtronic
    • Senseonics Holdings, Inc
    • GlySens Incorporated
    • DiaMonTech GmbH
    • Nemaura Medical Inc.
    • Integrity Applications, Inc.
    • CNOGA Medical Ltd.
    • Breath Health, Inc.
    • Metamaterial Technologies Inc.
    • Opticology Inc.
    • NovioSense BV
    • Quick LLC
    • RSP Systems A/S.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Modality
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Rising prevalence of diseases like myasthenia gravis and postoperative ileus requiring neostigmine
    • Restraints
  • Lack of knowledge and diagnosis
    • Opportunities
  • The growth of veterinary medicine
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Non-Invasive Blood Glucose Monitoring Devices Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • EM Waves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Transdermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Optical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Enzymatic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Modality, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Wearable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Non-wearable/Benchtop
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Embedded Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Non-Invasive Blood Glucose Monitoring Devices Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Homecare setting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub Region, 2020-2032,(US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dexcom, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Senseonics Holdings, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlySens Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DiaMonTech GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nemaura Medical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Integrity Applications, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CNOGA Medical Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Breath Health, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Metamaterial Technologies Inc.
  • Opticology Inc.
  • NovioSense BV
  • Quick LLC
  • RSP Systems A/S.
  • Analyst Views

10. Section

  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦